These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 3080872

  • 1. Acquired von Willebrand syndrome due to an inhibitor specific for von Willebrand factor antigens.
    Lazarchick J, Pappas AA, Kizer J, Hall SA.
    Am J Hematol; 1986 Mar; 21(3):305-14. PubMed ID: 3080872
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Acquired von Willebrand disease in patients with polycythemia rubra vera.
    Mohri H.
    Am J Hematol; 1987 Oct; 26(2):135-46. PubMed ID: 3116841
    [Abstract] [Full Text] [Related]

  • 5. Acquired von Willebrand disease due to inhibitor of human myeloma protein specific for von Willebrand factor.
    Mohri H, Noguchi T, Kodama F, Itoh A, Ohkubo T.
    Am J Clin Pathol; 1987 May; 87(5):663-8. PubMed ID: 3107370
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Selective absence of large forms of factor VIII/von Willebrand factor in acquired von Willebrand's syndrome. Response to transfusion.
    Meyer D, Frommel D, Larrieu MJ, Zimmerman TS.
    Blood; 1979 Sep; 54(3):600-6. PubMed ID: 313821
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An immunoradiometric assay for human factor VIII/von Willebrand factor (VIII:vWF) using a monoclonal antibody that defines a functional epitope.
    Goodall AH, Jarvis J, Chand S, Rawlings E, O'Brien DP, McGraw A, Hutton R, Tuddenham EG.
    Br J Haematol; 1985 Apr; 59(4):565-77. PubMed ID: 2580547
    [Abstract] [Full Text] [Related]

  • 15. Pathogenesis of antibody-induced acquired von Willebrand Syndrome.
    Gan TE, Sawers RJ, Koutts J.
    Am J Hematol; 1980 Apr; 9(4):363-71. PubMed ID: 6782864
    [Abstract] [Full Text] [Related]

  • 16. A critical evaluation of the available methods for the determination of factor VIII von Willebrand.
    Casonato A, Girolami A.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986 Apr; 113(5):670-84. PubMed ID: 2435633
    [Abstract] [Full Text] [Related]

  • 17. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
    Chediak J, Peake I, Bloom A.
    Thromb Haemost; 1983 Aug 30; 50(2):509-12. PubMed ID: 6415844
    [Abstract] [Full Text] [Related]

  • 18. Absence of a bleeding tendency in severe acquired von Willebrand's disease. The role of platelet von Willebrand factor in maintaining normal hemostasis.
    Drouin J, Lillicrap DP, Izaguirre CA, Sutherland M, Windsor S, Benford K, Hoogendorn H, Giles AR.
    Am J Clin Pathol; 1989 Oct 30; 92(4):471-8. PubMed ID: 2508465
    [Abstract] [Full Text] [Related]

  • 19. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ, Meyer D, Rabinowitz R, Pietu G, Girma JP, Vicic WJ, Rogers J.
    N Engl J Med; 1982 Feb 11; 306(6):326-33. PubMed ID: 6798442
    [Abstract] [Full Text] [Related]

  • 20. Additional variant of type I von Willebrand disease.
    Tavori S, Tatarsky I.
    Am J Hematol; 1987 Feb 11; 24(2):189-97. PubMed ID: 3101492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.